Eagle Pharmaceuticals, Inc. (EGRX) OTC

0.11

-1.495(-93.44%)

Updated at October 16 12:49PM

Currency In USD

Valuation

Market Cap369.26M
Enterprise Value369.26M
P/E Ratio0.04
PEG Ratio0
Price/Sales Ratio0
Price/Book Ratio0.01
Enterprise/Revenue0.04
Enterprise/EBITDA0.18

Fiscal Year

Fiscal YearMarch 31, 2023
Most Recent QuarterJune 30, 2023

Profitability

Profit Margin0.11
Operating Margin0.26

Management Effectiveness

Return On Assets0.09
Return On Equity0.17

Income Statement

Revenue316.61M
Revenue/Share24.48
Gross Profit221.67M
EBITDA77.5M
Net Income35.64M
Diluted EPS2.73

Balance Sheet

Total Cash15.35M
Total Cash/Share4.28
Total Debt71.61M
Total Debt/Equity0.29
Current Ratio1.7
Book Value Per Share18.06

Price History

52-Week Change-85
52-Week High3.87
52-Week Low0
Moving Average 50 Days2.93
Moving Average 200 Days2.12

Statistics

Average Volume1,734
Shares Outstanding12.99M
% Held by Institutions0.09

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A